These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25470003)

  • 1. Treating dyspnea with morphine sulfate in nonverbal children with neurological impairment.
    Hauer JM
    Pediatr Pulmonol; 2015 Apr; 50(4):E9-12. PubMed ID: 25470003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease.
    Janahi IA; Maciejewski SR; Teran JM; Oermann CM
    Pediatr Pulmonol; 2000 Sep; 30(3):257-9. PubMed ID: 10973044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
    Smallwood N; Le B; Currow D; Irving L; Philip J
    Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
    Gamborg H; Riis J; Christrup L; Krantz T
    J Opioid Manag; 2013; 9(4):269-74. PubMed ID: 24353020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients.
    Takeyasu M; Miyamoto A; Kato D; Takahashi Y; Ogawa K; Murase K; Mochizuki S; Hanada S; Uruga H; Takaya H; Morokawa N; Kishi K
    Intern Med; 2016; 55(7):725-9. PubMed ID: 27041155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose Morphine for Dyspnea in Terminally Ill Patients with Idiopathic Interstitial Pneumonias.
    Matsuda Y; Maeda I; Tachibana K; Nakao K; Sasaki Y; Sugimoto C; Arai T; Tokoro A; Akira M; Inoue Y
    J Palliat Med; 2017 Aug; 20(8):879-883. PubMed ID: 28437202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis.
    Cohen SP; Dawson TC
    Pediatrics; 2002 Sep; 110(3):e38. PubMed ID: 12205288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea.
    Zebraski SE; Kochenash SM; Raffa RB
    Life Sci; 2000; 66(23):2221-31. PubMed ID: 10855942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.
    Currow DC; McDonald C; Oaten S; Kenny B; Allcroft P; Frith P; Briffa M; Johnson MJ; Abernethy AP
    J Pain Symptom Manage; 2011 Sep; 42(3):388-99. PubMed ID: 21458217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized morphine for relief of dyspnea due to chronic lung disease.
    Brown SJ; Eichner SF; Jones JR
    Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midazolam as adjunct therapy to morphine to relieve dyspnea?
    Sironi O; Sbanotto A; Banfi MG; Beltrami C
    J Pain Symptom Manage; 2007 Mar; 33(3):233-4; author reply 234-6. PubMed ID: 17349490
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
    Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
    Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis.
    Allen S; Raut S; Woollard J; Vassallo M
    Palliat Med; 2005 Mar; 19(2):128-30. PubMed ID: 15810751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea.
    Currow DC; Quinn S; Greene A; Bull J; Johnson MJ; Abernethy AP
    J Palliat Med; 2013 Aug; 16(8):881-6. PubMed ID: 23746231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized opioids in the treatment of dyspnea.
    Quelch PC; Faulkner DE; Yun JW
    J Palliat Care; 1997; 13(3):48-52. PubMed ID: 9354041
    [No Abstract]   [Full Text] [Related]  

  • 18. Can we really say that nebulized morphine works?
    Lasheen W; Panneerselvam A; Davis MP
    J Pain Symptom Manage; 2006 Aug; 32(2):101-2; author reply 102-3. PubMed ID: 16877173
    [No Abstract]   [Full Text] [Related]  

  • 19. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized morphine in the palliation of dyspnoea.
    Zeppetella G
    Palliat Med; 1997 Jul; 11(4):267-75. PubMed ID: 9373577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.